Karen Cashmere

Karen Cashmere

Company: ZyVersa

Job title: Chief Commercial Officer


Panel Discussion: How to Characterise Rational Biomarkers/Endpoints? 3:30 pm

Exploring biomarker selection – clinical presence of inflammation in the diseases Utility in assessing disease progression and control of disease What is a clinically meaningful benchmark of inflammasome inhibition? What are the best tissue biomarkers of inflammasome inhibition? What biomarkers and assays should be measured in a phase 1 or phase 2 trial to demonstrate…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.